You are here

Invega Sustenna

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent

Reuters

Mon, 04/1/24 - 12:04 pm

Teva Pharmaceutical

Invega Sustenna

Johnson & Johnson’s stay-out-of-jail marketing for schizophrenia blockbuster Invega Sustenna raises eyebrows

Fierce Pharma

Thu, 02/15/18 - 11:46 pm

Invega Sustenna

J&J eyes long-acting boost for Invega franchise with quick FDA look at new formula

Fierce Pharma Marketing

Thu, 01/22/15 - 09:56 am

Invega Sustenna

Johnson & Johnson (JNJ) Wins Label Expansion Approval For Antipsychotic Drug

Bidness Etc.

Fri, 11/14/14 - 11:01 am

Invega Sustenna

3 Drugs Critical to Johnson & Johnson's Future

Motley Fool

Tue, 10/21/14 - 09:20 am

Invega Sustenna

Alkermes' Pipeline Development Impresses, Key Updates Ahead

Yahoo/Reuters

Tue, 07/22/14 - 08:54 am

Invega Sustenna

aripiprazole lauroxil

Pipeline Progress at Alkermes/JNJ

Yahoo/Zacks

Wed, 06/13/12 - 11:48 am

Invega Sustenna